Melanie Gloria
Net worth: 9 M $ as of 30/06/2026
Net worth: 9 M $ as of 30/06/2026
Melanie Gloria is currently Chief Operating Officer at Immunovant, Inc. since 2024.
Formerly, Ms. Gloria was Chief Operating Officer at ACELYRIN, Inc. from 2021 to 2024, Senior Vice President Development Operations at Emphusion LLC from 2018 to 2021, Senior Director-Clinical Development at AbbVie, Inc. from 2014 to 2018, and Associate Director-Clinical Program Development at Abbott Laboratories from 2009 to 2014.
Ms. Gloria completed undergraduate education at the University of Illinois.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOVANT INC 0.11% | 08/07/2026 | 222,357 ( 0.11% ) | 9 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Chief Operating Officer | 18/11/2024 |
| Companies | Position | End |
|---|---|---|
| ACELYRIN, INC. | Chief Operating Officer | 31/10/2024 |
Emphusion LLC
Emphusion LLC Data Processing ServicesTechnology Services Provides clinical data management and statistical services | Corporate Officer/Principal | 01/11/2021 |
| ABBVIE INC. | Corporate Officer/Principal | 01/07/2018 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/2014 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emphusion LLC
Emphusion LLC Data Processing ServicesTechnology Services Provides clinical data management and statistical services | Technology Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
ACELYRIN, Inc.
ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions